| HBAN |
Report |
Adjusted EPS |
BEAT |
pred ~$0.40 vs. cons $0.39 |
MEDIUM |
| HBAN |
Report |
Net Interest Income |
BEAT |
pred ~$1.95B vs. cons $1.91B |
MEDIUM |
| HBAN |
Report |
Noninterest (Fee) Income |
MISS |
pred ~$650M vs. cons $680M |
MEDIUM |
| HBAN |
Guide |
FY2026 Net Interest Margin guidance |
LOWER |
guide ~3.27% vs. cons 3.31% (FY2026) |
MEDIUM |
| HBAN |
Guide |
FY2026 Adjusted EPS guidance/consensus path |
LOWER |
guide ~$1.59 vs. cons $1.62 (FY2026) |
LOW |
| HBAN |
Guide |
FY2026 Fee income growth guidance |
LOWER |
guide ~29% vs. cons 32% (FY2026) |
MEDIUM |
| HBAN |
Guide |
2027 EPS target reiteration |
UNCHANGED |
guide ~$1.90-$1.93 vs. cons $1.91 (FY2027) |
HIGH |
| HBAN |
Guide |
2026 Share repurchase pace |
UNCHANGED |
guide ~$550M vs. prior guide $550M (FY2026) |
MEDIUM |
| HBAN |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.2% |
— |
MEDIUM |
| HBAN |
Return |
5-day cumulative residual |
-2.8% (FADE) |
Stock ran ~16% from June lows into the print, already pricing a clean Cadence conversion and continued fee momentum, so even a modest headline EPS beat likely triggers a 'sell-the-news' dip on day 1. Over the week, we expect analysts to trim FY26/FY27 NIM and fee-growth assumptions (elevated Fed cash balance persisting, tough capital-markets comp after Q1's record quarter, and reiterated-but-not-raised 2027 targets), pulling out-period estimates down and extending the initial pullback into a fade rather than stabilization. |
MEDIUM |